🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A comprehensive perioperative nutrition management plan for pancreaticoduod...
Status
Unknown
Location
Shanghai Ruijin Hospital
Start Date
2023-11-01
Trial ID
NCT06119880
Treatments Being Tested
The primary objective of this study was to evaluate the safety of a 2.0 mg/...
Status
Terminated
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01609062
Gaucher disease is an inherited deficiency of the lysosomal enzyme glucocer...
Status
Completed
Location
Hamamatsu University School of Medicine
Start Date
2012-03-02
Trial ID
NCT01614574
Treatments Being Tested
The study is divided into 2 parts. In the first part, the safety of the gen...
Status
Completed
Location
University of California at San Diego Medical Center
Start Date
2007-03
Trial ID
NCT00454818
Elaprase (idursulfase), a large molecular protein, is not expected to cross...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2009-11-18
Trial ID
NCT00920647
Treatments Being Tested
This was an open-label, repeat-dose, intra-participant dose-escalation stud...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-04
Trial ID
NCT01371825
Treatments Being Tested
The primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-03
Trial ID
NCT00446862
In August of 2014, the FDA approved ELELYSO for long-term enzyme replacemen...
Status
Withdrawn
Location
O&O Alpan LLC
Start Date
2019-07-31
Trial ID
NCT03021941
Treatments Being Tested
Fabry disease (FD) is a genetic condition where mutations in the GLA gene c...
Status
Active Not Recruiting
Location
Division of Cardiology, Department of Medicine and Therapeutics Faculty of Medicine, The Chinese University of Hong Kong
Start Date
2022-10-20
Trial ID
NCT07506083
The study will evaluate the safety and efficacy of Replagal® (agalsidase al...
Status
No Longer Available
Location
AKDHC Tucson Campbell
Start Date
TBD
Trial ID
NCT01031173
Treatments Being Tested